Vertex Pharmaceuticals (VRTX) announced several updates on the company’s type 1 diabetes portfolio. Vertex has completed enrollment and dosing in Parts A and B of the Phase 1/2 VX-264 study and ...

KING OF PRUSSIA, Pa., March 26, 2025 (GLOBE NEWSWIRE) -- Vertex Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of indirect tax technology solutions, reveals that while ...

Vertex Pharma has chosen the three-drug combination it intends to submit for approval later this year for cystic fibrosis, in a bid to add another product to its stable. The US company has plumped ...

Mar 29, 2025 Saudi Arabia Saudi Arabia Stock Exchange Eid al-Fitr Mar 30, 2025 Egypt Egypt Stock Exchange Eid al-Fitr ...

After hours: March 26 at 7:48:02 PM EDT Loading Chart for GWRE ...